Camp4 Therapeutics Grants 39,000 Stock Options to New Hires
Camp4 Therapeutics Corporation announced it granted non-qualified stock options to purchase an aggregate of 39,000 shares of its common stock to three newly hired employees on June 15, 2026. These inducement grants, made in accordance with Nasdaq Listing Rule 5635(c)(4), have an exercise price of $3.96 per share, matching the closing price on the grant date. The options will vest over a four-year period, with 25% vesting on the first anniversary and the remainder in 36 equal monthly installments, contingent on continued employment.
Key Highlights
- Granted 39,000 non-qualified stock options to three newly hired employees.
- Grants were made on June 15, 2026, as an inducement for employment.
- Exercise price per share is $3.96, equal to the closing price on the grant date.
- Options have a ten-year term.
- Vesting occurs over four years: 25% on the one-year anniversary, then 36 equal monthly installments.
- Grants are subject to continued service and Nasdaq Listing Rule 5635(c)(4).
Price Impact
More from CAMP
Camp4 Therapeutics Amends 2024 Equity Plan, Adopts 2026 Inducement Plan
CAMP4 CMP-002 Preclinical Data Improves Seizures in SYNGAP1 Disorder
Camp4 Therapeutics' CMP-002 Shows Significant Seizure Improvement in Preclinical Study